217 related articles for article (PubMed ID: 28472149)
1. Clinical characteristics of moderate-to-severe thyroid associated ophthalmopathy in 354 Chinese cases.
Li Q; Ye H; Ding Y; Chen G; Liu Z; Xu J; Chen R; Yang H
PLoS One; 2017; 12(5):e0176064. PubMed ID: 28472149
[TBL] [Abstract][Full Text] [Related]
2. Customized Orbital Decompression Surgery Combined with Eyelid Surgery or Strabismus Surgery in Mild to Moderate Thyroid-associated Ophthalmopathy.
Choi SW; Lee JY; Lew H
Korean J Ophthalmol; 2016 Feb; 30(1):1-9. PubMed ID: 26865797
[TBL] [Abstract][Full Text] [Related]
3. [Clinical Analysis of 2 170 Cases of Thyroid-Associated Ophthalmopathy Involving Extraocular Muscles].
Yang M; Du BX; Wang YJ; He WM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 May; 52(3):510-515. PubMed ID: 34018373
[TBL] [Abstract][Full Text] [Related]
4. Prevalence, risk factors, and clinical features of thyroid-associated ophthalmopathy in multiethnic Malaysian patients with Graves' disease.
Lim SL; Lim AK; Mumtaz M; Hussein E; Wan Bebakar WM; Khir AS
Thyroid; 2008 Dec; 18(12):1297-301. PubMed ID: 19012471
[TBL] [Abstract][Full Text] [Related]
5. Histopathologic study of extraocular muscles in thyroid-associated ophthalmopathy coexisting with ocular myasthenia gravis: a case report.
Ma R; Cheng Y; Gan L; Zhou X; Qian J
BMC Ophthalmol; 2020 Apr; 20(1):166. PubMed ID: 32321476
[TBL] [Abstract][Full Text] [Related]
6. Proptosis in dysthyroid ophthalmopathy: a case series of 10,931 Japanese cases.
Kozaki A; Inoue R; Komoto N; Maeda T; Inoue Y; Inoue T; Ayaki M
Optom Vis Sci; 2010 Mar; 87(3):200-4. PubMed ID: 20081550
[TBL] [Abstract][Full Text] [Related]
7. [Thyroid-associated ophthalmopathy: a clinical study of 381 cases].
Sun H; Jiao Q; Tan L; Wang S; Ning G; Zhao YJ
Zhonghua Nei Ke Za Zhi; 2006 May; 45(5):400-2. PubMed ID: 16780745
[TBL] [Abstract][Full Text] [Related]
8. [Clinical analysis of 403 cases of thyroid associated ophthalmopathy].
Wang YJ; He WM
Zhonghua Yan Ke Za Zhi; 2013 Aug; 49(8):685-90. PubMed ID: 24246805
[TBL] [Abstract][Full Text] [Related]
9. Changes of orbital tissue volumes and proptosis in patients with thyroid extraocular muscle swelling after methylprednisolone pulse therapy.
Higashiyama T; Nishida Y; Ohji M
Jpn J Ophthalmol; 2015 Nov; 59(6):430-5. PubMed ID: 26321629
[TBL] [Abstract][Full Text] [Related]
10. [The value of DCE-MRI in assessing the course of thyroid associated ophthalmopathy].
Wu T; Tang DR; Wang F; Xia S; Sun FY
Zhonghua Yan Ke Za Zhi; 2017 Jun; 53(6):430-435. PubMed ID: 28606264
[No Abstract] [Full Text] [Related]
11. [Extraocular muscle involvement in patients with thyroid-associated orbitopathy].
Karhanová M; Kovář R; Fryšák Z; Zapletalová J; Marešová K; Sín M; Heřman M
Cesk Slov Oftalmol; 2014 Apr; 70(2):66-71. PubMed ID: 25030316
[TBL] [Abstract][Full Text] [Related]
12. The significance of ophthalmological features in diagnosis of thyroid-associated ophthalmopathy.
Huang X; Tang W; Shen Y; He L; Tong F; Liu S; Li J; Li P; Zhang Y; Ma X; Wei R; Yang W
Biomed Eng Online; 2023 Feb; 22(1):7. PubMed ID: 36739403
[TBL] [Abstract][Full Text] [Related]
13. Correlation between extent of lacrimal gland prolapse and clinical features of thyroid-associated ophthalmopathy: a retrospective observational study.
Gao Y; Chang Q; Li Y; Zhang H; Hou Z; Zhang Z; Li Z; Li D
BMC Ophthalmol; 2022 Feb; 22(1):66. PubMed ID: 35144579
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of the ratio of orbital fat to total orbit area in mild-to-moderate thyroid-associated ophthalmopathy.
Kim HC; Yoon SW; Lew H
Br J Radiol; 2015 Sep; 88(1053):20150164. PubMed ID: 26151616
[TBL] [Abstract][Full Text] [Related]
15. Acquired lower eyelid epiblepharon in thyroid-associated ophthalmopathy of Koreans.
Park SW; Khwarg SI; Kim N; Lee MJ; Choung HK
Ophthalmology; 2012 Feb; 119(2):390-5. PubMed ID: 21978591
[TBL] [Abstract][Full Text] [Related]
16. Thyroid eye disease presenting with superior rectus/levator complex enlargement.
Wang Y; Mettu P; Broadbent T; Radke P; Firl K; Shepherd JB; Couch SM; Nguyen A; Henderson AD; McCulley T; McClelland CM; Mokhtarzadeh A; Lee MS; Garrity JA; Harrison AR
Orbit; 2020 Feb; 39(1):5-12. PubMed ID: 31056988
[No Abstract] [Full Text] [Related]
17. [Triamcinolone acetonide deep fornix injection for the treatment of upper eyelid retraction in patients with thyroid-associated ophthalmopathy].
Luo LH; Gao LX; Wang W; Miao H; Ma XM; Li DM
Zhonghua Yan Ke Za Zhi; 2020 Jul; 56(7):524-529. PubMed ID: 32842335
[No Abstract] [Full Text] [Related]
18. The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota.
Bartley GB
Trans Am Ophthalmol Soc; 1994; 92():477-588. PubMed ID: 7886878
[TBL] [Abstract][Full Text] [Related]
19. Teprotumumab for patients with active thyroid eye disease: a pooled data analysis, subgroup analyses, and off-treatment follow-up results from two randomised, double-masked, placebo-controlled, multicentre trials.
Kahaly GJ; Douglas RS; Holt RJ; Sile S; Smith TJ
Lancet Diabetes Endocrinol; 2021 Jun; 9(6):360-372. PubMed ID: 33865501
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance imaging determination of extraocular eye muscle volume in patients with thyroid-associated ophthalmopathy and proptosis.
Kvetny J; Puhakka KB; Røhl L
Acta Ophthalmol Scand; 2006 Jun; 84(3):419-23. PubMed ID: 16704711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
